A new trend gaining popularity among people trying to loseweight is microdosing the diabetes medication Ozempic. With approximately 70% of American adults meeting the criteria for being obese ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...